Austar Lifesciences Limited (HKG:6118)

Market Cap	420.32M +5.1%
Revenue (ttm)	1.70B +2.0%
Net Income	37.62M +110.2%
EPS	0.07 +110.2%
Shares Out	512.58M
PE Ratio	11.17
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	19,000
Average Volume	126,100
Open	0.8000
Previous Close	0.8200
Day's Range	0.8000 - 0.8200
52-Week Range	0.6500 - 1.9700
Beta	0.91
RSI	54.67
Earnings Date	May 26, 2026

About Austar Lifesciences

Austar Lifesciences Limited, an investment holding company, engages in the provision of integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally. The company operates through Integrated Process and Packaging Equipment & Systems (IPS); Consulting, Digitalization and Construction (CDC); and Life Science Equipment and Consumables (SIC) segments. It also offers clean utility and bioprocess equipment, clean room, automation control and monitor system; bioprocess equipment consumab...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1991
• Employees: 1,468
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 6118

Financial Performance

In 2025, Austar Lifesciences's revenue was 1.53 billion, an increase of 2.02% compared to the previous year's 1.50 billion. Earnings were 33.81 million, an increase of 110.24%.

Financial numbers in CNY